Peeling paint, unsanitary practices among issues at U.S. plant making J&J COVID-19 vaccine -FDA

A U.S. plant that was making Johnson & Johnson’s (JNJ.N) COVID-19 vaccine must fix a long list of problems including peeling paint and unsanitary conditions and practices to resume operation, according to a highly critical report by the Food and Drug Administration.

Read the full article here

Related Articles